Optimal intravenous antiplatelet therapy in patients with ST-elevation myocardial infarction: is the picture becoming clearer?

被引:0
|
作者
Farag, Mohamed [1 ,2 ]
机构
[1] Freeman Rd Hosp, Cardiothorac Dept, Newcastle Upon Tyne NE7 7DN, England
[2] Univ Hertfordshire, Sch Life & Med Sci, Hatfield, Herts, England
关键词
PLATELET INHIBITION; CANGRELOR; PCI;
D O I
10.1007/s11239-024-02999-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:754 / 756
页数:3
相关论文
共 50 条
  • [1] Pretreatment with dual antiplatelet therapy in patients with ST-elevation myocardial infarction
    Yudi, Matias B.
    Farouque, Omar
    Andrianopoulos, Nick
    Ajani, Andrew E.
    Brennan, Angela
    Lefkovits, Jeffrey
    Reid, Christopher M.
    Chan, William
    Duffy, Stephen J.
    Clark, David J.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (02) : E98 - E105
  • [2] Optimal antiplatelet and antithrombotic therapy in patients with ST elevation myocardial infarction
    Kozinski, Marek
    Grzesk, Grzegorz
    Kubica, Jacek
    KARDIOLOGIA POLSKA, 2012, 70 (02) : 206 - 212
  • [3] ST-elevation myocardial infarction: the role of adjunctive antiplatelet therapy
    Boden, William E.
    Hoekstra, James
    Miller, Chadwick D.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2008, 26 (02): : 212 - 220
  • [4] Antiplatelet therapy in patients with ST-elevation myocardial infarction undergoing myocardial revascularisation: beyond clopidogrel
    Jukema, J. Wouter
    Collet, Jean-Philippe
    De Luca, Leonardo
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (02) : 203 - 211
  • [5] Fibrinolytic therapy in patients with ST-elevation myocardial infarction
    Solhpour, Amirreza
    Yusuf, Syed W.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (02) : 201 - 215
  • [6] Impact of antiplatelet therapy on microvascular thrombosis during ST-elevation myocardial infarction
    Khattak, Sophia
    Townend, Jonathan N.
    Thomas, Mark R.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
  • [7] ST-elevation myocardial infarction in patients not undergoing reperfusion therapy: enoxaparin and dual antiplatelet therapy can be the best solution. The Romanian registry for ST-elevation myocardial
    Tatu-Chitoiu, G.
    Dorobantu, M.
    Benedek, I.
    Craiu, E.
    Sinescu, Crina.
    Ionescu, D. D.
    Olariu, C.
    Radoi, M.
    Pop, C.
    Macarie, C.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2010, 12 (0F) : F33 - F33
  • [8] Optimal pharmacological therapy in ST-elevation myocardial infarction-a review
    Hermanides, R. S.
    Kilic, S.
    van't Hof, A. W. J.
    NETHERLANDS HEART JOURNAL, 2018, 26 (06) : 296 - 310
  • [9] ST-Elevation Myocardial Infarction Patients with Hyperglycemia: Effects of Intravenous Adenosine
    Mone, Pasquale
    Pansini, Antonella
    Rizzo, Mario
    Minicucci, Fabio
    Mauro, Ciro
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2022, 363 (02): : 122 - 129
  • [10] Antiplatelet agents make a comeback in ST-elevation myocardial infarction
    Wiviott, Stephen D.
    de Lemos, James A.
    AMERICAN HEART JOURNAL, 2007, 154 (04) : 603 - 606